Jaundice as a Rare Manifestation of Epstein-Barr Virus Primary Infection
- PMID: 34277228
- PMCID: PMC8275053
- DOI: 10.7759/cureus.15609
Jaundice as a Rare Manifestation of Epstein-Barr Virus Primary Infection
Abstract
Epstein-Barr virus (EBV) primary infection usually presents with classic symptoms of infectious mononucleosis (IM) like fever, lymphadenopathies and tonsillopharyngitis. Liver damage is frequently mild and self-limited and there are only a few cases of severe EBV-induced cholestatic hepatitis and jaundice reported in the literature. The authors present the case of a 22-year-old woman who was admitted with acute fever and jaundice. Physical examination revealed posterior cervical lymphadenopathies and painful hepatosplenomegaly. Laboratorial findings suggested an obstructive cause for jaundice but ultrasound and magnetic resonance cholangiopancreatography excluded biliary duct pathology. Heterophile antibodies were negative but EBV-specific antibodies revealed isolated positive viral capsid antigen (VCA) immunoglobin (Ig) M suggesting the diagnosis of early phase of EBV primary infection. The diagnosis of EBV-induced cholestatic hepatitis was confirmed after identification of EBV deoxyribonucleic acid (DNA) in blood and by liver biopsy. Supportive management was provided and, despite an initial clinical deterioration, the patient had a favorable outcome. EBV is a virus with a high prevalence worldwide, mainly subclinical, and jaundice is a rare manifestation of the infection. Although the majority of the patients recover without sequelae, progression to liver failure has been described and a careful assessment for complications is mandatory. Therefore, EBV infection should be included in the comprehensive differential diagnosis of jaundice in all age groups.
Keywords: cholestasis; epstein–barr virus; hepatitis; infectious mononucleosis; jaundice.
Copyright © 2021, Rodrigues Santos et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Epstein-Barr virus and cytomegalovirus infections of the liver. Bunchorntavakul C, Reddy KR. Gastroenterol Clin North Am. 2020;49:331–346. - PubMed
-
- Epstein-Barr virus infection. Cohen JI. N Engl J Med. 2000;343:481–492. - PubMed
-
- The role of Epstein-Barr virus in acute and chronic hepatitis. Drebber U, Kasper HU, Krupacz J, et al. J Hepatol. 2006;44:879–885. - PubMed
-
- Epstein Barr virus hepatitis. Kofteridis DP, Koulentaki M, Valachis A, Christofaki M, Mazokopakis E, Papazoglou G, Samonis G. Eur J Intern Med. 2011;22:73–76. - PubMed
-
- Manifestations of Epstein-Barr virus-associated disorders in liver. Markin RS. Liver. 1994;14:1–13. - PubMed
Publication types
LinkOut - more resources
Full Text Sources